Suvi Marjasuo

University of Helsinki

Papers

1

Total Citations

17

H-Index

1

About

Suvi Marjasuo is a leading researcher in urologic oncology, with a primary focus on improving prostate cancer risk stratification through the integration of advanced imaging. Her most cited work demonstrates how prostate multiparametric MRI (mpMRI) significantly enhances the predictive accuracy of established clinical nomograms—including CAPRA, MSKCC, and Partin—for forecasting adverse pathology and biochemical recurrence after radical prostatectomy. This 2020 study, which has garnered 17 citations, underscores her contribution to bridging the gap between traditional risk models and modern imaging, offering clinicians a more precise tool for treatment planning. Conducted at HUS Helsinki University Hospital, Marjasuo’s research is pivotal in personalizing prostate cancer management, potentially reducing overtreatment while identifying high-risk patients earlier. Her work is highly regarded for its practical impact on surgical decision-making and postoperative outcomes, marking her as a key figure in the evolving landscape of precision oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
17
Total Citations
17
Avg Citations/Paper
🏆 Most Cited Paper
Prostate MRI added to CAPRA, MSKCC and Partin cancer nomograms significantly enhances the prediction of adverse findings and biochemical recurrence after radical prostatectomy
17 citations · 2020
📈 Most Prolific Year: 2020 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: University of Helsinki

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago